Moarbess G.; El-Hajj H.; Kfoury Y.; El-Sabban M.E.; Lepelletier Y.; Hermine O.; Deleuze-Masquefa C.; Bonnet P.-A.; Bazarbachi A.
(WASHINGTON1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA, 2008)
Imiquimod is an immune response modifier currently used as a topical treatment of genital warts, basal cell carcinoma, cutaneous metastasis of malignant melanoma, and vascular tumors. We developed more efficient killers ...